Market report: City cheers GSK’s recovery
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The ink is barely dry on the turnaround plan at GlaxoSmithKline but the City is already cheering the drug maker’s recovery.
After beating expectations with third-quarter profits and announcing plans for a £1bn cost-cutting drive, Barclays said “laggard” GSK was now “out of the woods”. Plans for a £4bn cash return for shareholders also quashed dividend worries and the bank upped the company to “outperform” with a £16 target price. The endorsement helped GSK rise 35p to 1,412p.
After falling more than 1 per cent in early trade, the blue-chip index managed to recover from bleak figures at Tesco, down 12p at 171p, and poor drilling results in Kenya from Tullow Oil, off 22p at 505.5p. The FTSE 100 closed up 19.42 points at 6,419.15.
The British Airways owner IAG topped the index, up 12.8p at 384p, after Credit Suisse added the company to its list of top picks in Europe, arguing that BA has a chance of beating expectations and building a profitable short-haul operation.
BP improved 4.7p to 438.95p after the oil and gas giant announced a major new find in the North Sea.
Car showroom operator Inchcape added 33.5p to 667p on the mid-cap index thanks to a 4.4 per cent rise in third-quarter revenue once exchange rates are factored in.
Photo-booth operator Photo-Me International jumped 9.5p to 128p after confirming it is on track to meet full-year targets.
Silicon Valley venture capital firm Greylock Partners reduced its holding in Just Eat, down 0.7p at 280p, from 4.19 per cent to below 3 per cent.
Akers Biosciences leapt 7.5p to 240p after announcing a joint venture that will see some of its rapid diagnostic products developed and marketed in China.
C4X Discovery, a drug development company spun out of the University of Manchester, had its first day of dealing on AIM after successfully raising £11m. The company rose to 103.5p after being offered at 100p.
Baron Oil improved 0.12p to 1.6p on AIM after receiving drilling approval in Peru. It also revealed it has discovered additional oil and gas reserves at one of its offshore blocks.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments